Analytical Data
-
Gene name
S100A7L2
- Application
-
Alternative Names
S100A7L2; S100A7B; Protein S100-A7-like 2; S100 calcium-binding protein A7-like 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5SY68
-
Expression Region
1-101 aa
-
AA Sequence
MNIPLGEKVM LDIVAMFRQY SGDDGRMDMP GLVNLMKENF PNFLSGCEKS DMDYLSNALE KKDDNKDKKV NYSEFLSLLG DITIDHHKIM HGVAPCSGGS Q
-
Molecular Weight
11.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A7L2, a member of the S100 protein family, is characterized by its EF-hand type calcium-binding motifs and is primarily expressed in epithelial tissues. Its role has emerged as significant in various biological processes, including cellular growth, differentiation, and inflammation. Research indicates that S100A7L2 may be involved in the pathogenesis of several diseases, including cancer, due to its regulatory impact on cell signaling pathways and immune responses. Recent studies have highlighted its potential as a biomarker for certain conditions and a target for therapeutic interventions. The recombinant protein of S100A7L2 has been generated to facilitate in-depth studies on its biological functions, interactions, and mechanisms of action. Understanding the properties and roles of S100A7L2 in health and disease could provide valuable insights into potential diagnostic and therapeutic strategies, warranting further investigation in both basic and clinical research settings.
